Allstate Corp Theravance Biopharma, Inc. Transaction History

Allstate Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$6.77 - $14.41 $99,390 - $211,553	-14,681 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$14.52 - $22.46 $1,785 - $2,762	123 Added 0.84%	14,681 $213,000
Q1 2021 May 14, 2021	BUY	$16.57 - $21.08 $35,642 - $45,343	2,151 Added 17.34%	14,558 $297,000
Q4 2020 Feb 12, 2021	BUY	$14.89 - $20.16 $184,740 - $250,125	12,407 New	12,407 $220,000
Q2 2020 Aug 13, 2020	SELL	$20.64 - $30.69 $194,717 - $289,529	-9,434 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$17.84 - $31.21 $168,302 - $294,435	9,434 New	9,434 $218,000

134

48.7M

13.9K

3.1K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $541M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

Stay updated on Allstate Corp with notifications on news.